Astrid Mulenga
Overview
Explore the profile of Astrid Mulenga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chabikuli O, Ditekemena J, Sigwadhi L, Mulenga A, Mboyo A, Bidashimwa D, et al.
J Int Assoc Provid AIDS Care
. 2023 Dec;
22:23259582231221955.
PMID: 38146172
Little is known about advanced HIV disease (AHD) at antiretroviral therapy (ART) initiation among children and adolescents living with HIV (CALHIV) and related age disparities in the Democratic Republic of...
2.
Shah G, Etheredge G, Smallwood S, Maluantesa L, Waterfield K, Ikhile O, et al.
South Afr J HIV Med
. 2022 Nov;
23(1):1421.
PMID: 36353191
Background: The coronavirus disease 2019 (COVID-19) pandemic resulted in unique programmatic opportunities to test hypotheses related to the initiation of antiretroviral treatment (ART) and viral load (VL) suppression during a...
3.
Shah G, Etheredge G, Maluantesa L, Waterfield K, Ikhile O, Engetele E, et al.
Front Public Health
. 2022 Oct;
10:912787.
PMID: 36262234
Background: Orphans and vulnerable children (OVC) are a high-risk group for HIV infection, particularly in Sub-Saharan Africa. Purpose: This study aims to portray the socioeconomic profile of OVC and examine...
4.
Shah G, Etheredge G, Schwind J, Maluantesa L, Waterfield K, Mulenga A, et al.
Healthcare (Basel)
. 2022 Aug;
10(8).
PMID: 36011173
The impact of the COVID-19 pandemic extends beyond the immediate physical effects of the virus, including service adjustments for people living with the human immunodeficiency virus (PLHIV) on antiretroviral therapy...
5.
Shah G, Maluantesa L, Etheredge G, Waterfield K, Ikhile O, Beni R, et al.
Healthcare (Basel)
. 2022 Jan;
10(1).
PMID: 35052234
Purpose: This study had two objectives-(a) to describe the levels of HIV VL in persons on antiretroviral therapy (ART), and (b) to analyze the significance of variation in VL by...
6.
Ewetola R, Shah G, Maluantesa L, Etheredge G, Waterfield K, Mulenga A, et al.
Int J Environ Res Public Health
. 2021 Jun;
18(10).
PMID: 34067847
Context: In this era of patient-centered care, it is increasingly important for HIV/AIDS care and treatment programs to customize their services according to patients' clinical stage progression and other risk...